BMRN BioMarin Pharmaceutical Inc.
BMRN BioMarin Pharmaceutical Inc.
Healthcare · Biotechnology
Market read
Scan convergence 1 scan as of 2026-10-16 1 neutral converging
POC $55.14 · VWAP $57.70 · -3.0% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
2 watchlists
BMRN Price Structure
Loading timeframes…
Peers
Every watchlist BMRN belongs to, members best 30-day change first — BMRN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@ibb
@biotech-scan
Reported the quarter ending 2026-06-30: revenue $990M, diluted EPS $0.23, net income $45M (SEC filing). Across the print the stock moved +6.5% (close before → first close after).
full note →Against street estimates
How BMRN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about BMRN from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 14 days ago · Oct 9
- BioMarin News - Recent Updates & Announcements
- BioMarin Pharmaceutical (LON:0HNC) Stock Price & Overview
- BioMarin Pharmaceutical Earnings & Forecasts - Benzinga
- BioMarin Pharmaceutical Inc. (BMRN) Stock Price, News, Quote & History - Yahoo Finance
- BMRN 8-K Filings - BioMarin Pharmaceuticals Inc SEC 8-K
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
BMRN research tape
41 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.